|
24
|
143
|
12zjA |
Crystal structure of usp7 traf domain in complex with magel2 peptide (968-980) |
|
0
|
10
|
12zjB |
Crystal structure of usp7 traf domain in complex with magel2 peptide (968-980) |
|
60
|
258
|
9n97A |
Crystal structure of the cysteine-free anti-utag intrabody |
|
42
|
246
|
9kftS |
Cryo-em structure of the fmlfc-fpr1-gi complex |
|
106
|
296
|
9kftR |
Cryo-em structure of the fmlfc-fpr1-gi complex |
|
72
|
336
|
9kftB |
Cryo-em structure of the fmlfc-fpr1-gi complex |
|
60
|
353
|
9kftA |
Cryo-em structure of the fmlfc-fpr1-gi complex |
|
10
|
54
|
9kftC |
Cryo-em structure of the fmlfc-fpr1-gi complex |
|
330
|
867
|
9tdaA |
Erap1 in complex with 1-[2-(5-bromo-7-fluoro-2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetamido]-4,4-difluorocyclohexane-1-carboxylic acid |
|
219
|
744
|
9bj9D |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
209
|
744
|
9bj8D |
Human crl2-zyg11b complex |
|
168
|
721
|
9bidA |
Human zyg11b and eloginb/c complex |
|
206
|
721
|
9bj9A |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
197
|
721
|
9bj8A |
Human crl2-zyg11b complex |
|
203
|
721
|
9bieA |
Human zyg11b elonginb/c complex binding to sars-cov2 orf10 protein |
|
18
|
96
|
9bidC |
Human zyg11b and eloginb/c complex |
|
7
|
98
|
9bidB |
Human zyg11b and eloginb/c complex |
|
12
|
98
|
9bj8B |
Human crl2-zyg11b complex |
|
7
|
90
|
9bj9R |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
23
|
96
|
9bj8C |
Human crl2-zyg11b complex |
|
22
|
96
|
9bj9C |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
8
|
90
|
9bj8R |
Human crl2-zyg11b complex |
|
0
|
21
|
9bj9P |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
9
|
98
|
9bieB |
Human zyg11b elonginb/c complex binding to sars-cov2 orf10 protein |
|
1
|
15
|
9bieP |
Human zyg11b elonginb/c complex binding to sars-cov2 orf10 protein |
|
20
|
96
|
9bieC |
Human zyg11b elonginb/c complex binding to sars-cov2 orf10 protein |
|
12
|
98
|
9bj9B |
Human crl-2 zyg11b binding to human nlrp1 gly/n degron |
|
95
|
254
|
9x41R |
Ar234958 bound mas1 receptor |
|
12
|
55
|
9x40G |
Ar234958 bound mas1 receptor complex |
|
63
|
357
|
9x40A |
Ar234958 bound mas1 receptor complex |
|
92
|
254
|
9x40R |
Ar234958 bound mas1 receptor complex |
|
43
|
245
|
9x40S |
Ar234958 bound mas1 receptor complex |
|
87
|
335
|
9x40B |
Ar234958 bound mas1 receptor complex |
|
56
|
174
|
9t9fA |
Crystal structure of human chd1 tandem chromodomain in complex with the ethoxyquinoline-based inhibitor 2l |
|
55
|
174
|
9t9eA |
Crystal structure of human chd1 tandem chromodomain in complex with the ethoxyquinoline-based inhibitor 2b |
|
58
|
174
|
9t9gA |
Crystal structure of human chd1 tandem chromodomain in complex with the ethoxyquinazoline-based inhibitor 1q |
|
107
|
304
|
10tcA |
Structure of wdr5 bound to rbbp5 (d376n) |
|
0
|
8
|
10tcB |
Structure of wdr5 bound to rbbp5 (d376n) |
|
57
|
174
|
9t9iA |
Crystal structure of human chd1 tandem chromodomain in complex with the ethoxyquinoline-based inhibitor 2s |
|
57
|
174
|
9t9hA |
Crystal structure of human chd1 tandem chromodomain in complex with the ethoxyquinoline-based inhibitor 2n |
|
81
|
255
|
9xhrA |
Crystal structure of human cathepsin b with a d-peptide substrate |
|
45
|
113
|
9v9aA |
Crystal structure of the periplasmic domain of cadf from campylobacter jejuni in complex with glycine |
|
253
|
689
|
9rvaA |
Crystal structure of the extracellular part of human ace2 in complex with the macrocyclic peptide wjl-63 |
|
45
|
114
|
9v99A |
Crystal structure of the periplasmic domain of cadf from campylobacter jejuni in complex with a peptidoglycan peptide |
|
73
|
254
|
9va8A |
Crystal structure of human cathepsin b with a l-peptide substrate |
|
41
|
113
|
9v9bA |
Crystal structure of the periplasmic domain of campylobacter jejuni cadf r268e |
|
6
|
25
|
9uthB |
Dpf3b in complex with h3k14cr peptide |
|
26
|
113
|
9uthA |
Dpf3b in complex with h3k14cr peptide |
|
0
|
18
|
9rvaC |
Crystal structure of the extracellular part of human ace2 in complex with the macrocyclic peptide wjl-63 |
|
328
|
866
|
9td3A |
Erap1 in complex with 1-[2-(6-bromo-2,2-difluoro-3-oxo-3,4-dihydro-2h-1,4-benzoxazin-4-yl)acetamido]cyclohexane-1-carboxylic acid |
